| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO R GBP CAP | RVI EMERGENTES | 27,03% | · | · | · |
| JPM EUROPE SMALL CAP C (DIST) EUR | RVI EUROPA SMALL/MID CAP | 27,03% | 38,91% | 29,62% | 83,36% |
| AMUNDI MSCI EMERGING MARKETS ESG BROAD TRANSITION UCITS ETF DR CAP | RVI EMERGENTES | 27,02% | 41,40% | 31,82% | · |
| GOLDMAN SACHS EUROPE CORE EQUITY PORTFOLIO I EUR DIS | RVI EUROPA | 27,02% | 58,31% | 74,94% | 131,45% |
| SCHRODER ISF ALL CHINA EQUITY Y ACC USD | RVI CHINA | 27,02% | -1,41% | -11,31% | · |
| AVIVA INVESTORS - GLOBAL EMERGING MARKETS CORE I USD | RVI EMERGENTES | 27,01% | 44,66% | 28,59% | 97,23% |
| FIDELITY FUNDS-ASIA EQUITY ESG Y-ACC-USD | RVI ASIA EX-JAPÓN | 27,01% | 23,99% | 12,64% | 153,56% |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 27,01% | -0,46% | -42,02% | · |
| SPDR MSCI EMERGING MARKETS UCITS ETF | RVI EMERGENTES | 27,01% | 43,73% | 28,13% | 147,37% |
| UBS MSCI EM INDEX FUND USD I-B ACC | RVI EMERGENTES | 27,01% | · | 27,42% | 145,81% |
